Literature DB >> 19727265

Use of atypical antipsychotics in the elderly.

Elisa Cascade1, Amir H Kalali, Jeffrey L Cummings.   

Abstract

Recent research on dementia patients suggests that use of antipsychotics may increase risk of hospitalization or death. While bipolar disorder and schizophrenia combine to represent more than 70 percent of atypical antipsychotic uses in younger patients, these same indications represent only 38 percent of product use in patients age 65 and older. The difference between the two age groups is driven primarily by use in cognitive impairment: Dementia and Alzheimer's combine to account for 28 percent of atypical antipsychotic use in older patients. Although ICD-9 coding tends to group patients into less specific diagnoses, we did isolate a small group of approximately 10 percent of patients that were classified based on the presence or absence of behavior disturbances. Eighteen percent of dementia patients without behavioral disturbances received atypical antipsychotics as compared to 66 percent of patients with behavioral disturbances. A discussion of the results is provided.

Entities:  

Keywords:  Alzheimer’s; antipsychotics; dementia

Year:  2008        PMID: 19727265      PMCID: PMC2695730     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  14 in total

1.  Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Authors:  Lon S Schneider; Pierre N Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; T Scott Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

2.  Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.

Authors:  Peter Paul De Deyn; Ira R Katz; Henry Brodaty; Benjamin Lyons; Andrew Greenspan; Alistair Burns
Journal:  Clin Neurol Neurosurg       Date:  2005-10       Impact factor: 1.876

3.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study.

Authors:  Kate X Zhong; P N Tariot; J Mintzer; M C Minkwitz; N A Devine
Journal:  Curr Alzheimer Res       Date:  2007-02       Impact factor: 3.498

5.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

6.  Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.

Authors:  Helen C Kales; Marcia Valenstein; H Myra Kim; John F McCarthy; Dara Ganoczy; Francesca Cunningham; Frederic C Blow
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

Review 7.  Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies.

Authors:  Jeffrey L Cummings; Kate Zhong
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

Review 8.  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.

Authors:  Dilip V Jeste; Dan Blazer; Daniel Casey; Thomas Meeks; Carl Salzman; Lon Schneider; Pierre Tariot; Kristine Yaffe
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

9.  Antipsychotic drug use and risk of pneumonia in elderly people.

Authors:  Wilma Knol; Rob J van Marum; Paul A F Jansen; Patrick C Souverein; Alfred F A M Schobben; Antoine C G Egberts
Journal:  J Am Geriatr Soc       Date:  2008-02-07       Impact factor: 5.562

10.  Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.

Authors:  S Gauthier; H Loft; J Cummings
Journal:  Int J Geriatr Psychiatry       Date:  2008-05       Impact factor: 3.485

View more
  1 in total

Review 1.  An update on the diagnosis and management of dementing conditions.

Authors:  Marwan Maalouf; John M Ringman; Jiong Shi
Journal:  Rev Neurol Dis       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.